A defective MMR system can lead to accelerated accumulation of somatic mutations resulting in carcinogenesis with approximately 70–90% of LS attributable to deleterious mutations in MLH1 and MSH2, and 10–30% distributed between lower penetrance MSH6 and PMS2 genes [1,5,6]. The gene discussed is PMS2; the disease is Leigh syndrome.